Decreasingpfmdr1Copy Number inPlasmodium falciparumMalaria Heightens Susceptibility to Mefloquine, Lumefantrine, Halofantrine, Quinine, and Artemisinin

This publication has 44 references indexed in Scilit:

• A Systematic Map of Genetic Variation in Plasmodium falciparum
  PLoS Pathogens, 2006
• Molecular and Pharmacological Determinants of the Therapeutic Response to Artemether-Lumefantrine in Multidrug-Resistant Plasmodium falciparum Malaria
  Clinical Infectious Diseases, 2006
• Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance
  Trends in Molecular Medicine, 2006
• Amplification ofPlasmodium falciparumMultidrug Resistance Gene 1 in Isolates from Gabon
  The Journal of Infectious Diseases, 2005
• Efficacy of Artesunate Plus Amodiaquine versus That of Artemether-Lumefantrine for the Treatment of Uncomplicated Childhood Plasmodium falciparum Malaria in Zanzibar, Tanzania
  Clinical Infectious Diseases, 2005
• pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum
  Molecular Microbiology, 2005
• In Vivo Selection ofPlasmodium falciparum pfmdr186N Coding Alleles by Artemether‐Lumefantrine (Coartem)
  The Journal of Infectious Diseases, 2005
• Complex Polymorphisms in an ∼330 kDa Protein Are Linked to Chloroquine-Resistant P. falciparum in Southeast Asia and Africa
  Cell, 1997
• Stage-specific transcripts of the Plasmodium falciparum pfmdr1 gene
  Molecular and Biochemical Parasitology, 1993
• A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole.
  The Journal of cell biology, 1991